Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Switching Between Glucagon-Like Peptide-1 Receptor Agonists: Rationale and Practical Guidance
Relevant literature was reviewed in conjunction with the authors clinical experience
The US GLP-1 user population is large and growing, and current government policy and drug-provider pricing strategies are breaking down adoption barriers and may make it grow faster, said Rick Miller, partner and marketing effectiveness practice lead at Big Chalk
.webp)
severe gastrointestinal disease or gastroparesis
The study authors note that this effect size is similar to what is observed with many approved drug therapies, minus the side effects and costs
US$ 22.31
US$ 20.22
US$ 20.40
US$ 20.87
US$ 23.24
US$ 28.04
US$ 25.85
